Literature DB >> 2535719

Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.

C H Jones1, S D Hayward, D R Rawlins.   

Abstract

The Epstein-Barr virus (EBV) nuclear antigen EBNA-1 plays an integral role in the maintenance of latency in EBV-infected B lymphocytes. EBNA-1 binds to sequences within the plasmid origin of replication (oriP). It is essential for the replication of the latent episomal form of EBV DNA and may also regulate the expression of the EBNA group of latency gene products. We have used sequence-specific DNA-binding assays to purify EBNA-1 away from nonspecific DNA-binding proteins in a B-lymphocyte cell extract. The availability of this eucaryotic protein has allowed an examination of the interaction of EBNA-1 with its specific DNA-binding sites and an evaluation of possible roles for the different binding loci within the EBV genome. DNA filter binding assays and DNase I footprinting experiments showed that the intact Raji EBNA-1 protein recognized the two binding site loci in oriP and the BamHI-Q locus and no other sites in the EBV genome. Competition filter binding experiments with monomer and multimer region I consensus binding sites indicated that cooperative interactions between binding sites have relatively little impact on EBNA-1 binding to region I. An analysis of the binding parameters of the Raji EBNA-1 to the three naturally occurring binding loci revealed that the affinity of EBNA-1 for the three loci differed. The affinity for the sites in region I of oriP was greater than the affinity for the dyad symmetry sites (region II) of oriP, while the physically distant region III locus showed the lowest affinity. This arrangement may provide a mechanism whereby EBNA-1 can lowest affinity. This arrangement may provide a mechanism whereby EBNA-1 can mediate differing regulatory functions through differential binding to its recognition sequence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535719      PMCID: PMC247662     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Opportunistic cancers in patients with immunodeficiency syndromes.

Authors:  D T Purtilo
Journal:  Arch Pathol Lab Med       Date:  1987-12       Impact factor: 5.534

2.  Electron microscopy of binding of Epstein-Barr virus (EBV) nuclear antigen (EBNA-1) to EBV DNA.

Authors:  J Reischig; D Bartsch; A Polack; V Vonka; I Hirsch
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

3.  A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.

Authors:  M Bodescot; M Perricaudet; P J Farrell
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons.

Authors:  S H Speck; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  An Epstein-Barr virus transcription unit is at least 84 kilobases long.

Authors:  M Bodescot; O Brison; M Perricaudet
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

6.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

Authors:  D Reisman; B Sugden
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

7.  Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.

Authors:  J Sample; M Hummel; D Braun; M Birkenbach; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.

Authors:  J Dillner; B Kallin; H Alexander; I Ernberg; M Uno; Y Ono; G Klein; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.

Authors:  G Milman; A L Scott; M S Cho; S C Hartman; D K Ades; G S Hayward; P F Ki; J T August; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome.

Authors:  G Laux; M Perricaudet; P J Farrell
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  50 in total

1.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  The linking regions of EBNA1 are essential for its support of replication and transcription.

Authors:  D Mackey; B Sugden
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.

Authors:  P R Smith; B E Griffin
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.

Authors:  J Sample; E B Henson; C Sample
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin.

Authors:  L Frappier; M O'Donnell
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions.

Authors:  W A Shah; R F Ambinder; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.

Authors:  L Frappier; M O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

9.  DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1.

Authors:  W Su; T Middleton; B Sugden; H Echols
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

10.  Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.

Authors:  J Sample; L Brooks; C Sample; L Young; M Rowe; C Gregory; A Rickinson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.